AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7536438
Drug: Intradermal recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 100 U daily for 5 days (group C)
Trial: 7536438
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (100 U and 5000 U, single injections; 100 U, multiple injections)
Trial: 1665184
Drug: Lisinopril-hydrochlorothiazide (L/HCTZ)
RxNorm normalized name: fosinopril / hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril-hydrochlorothiazide (L/HCTZ) 20 mg/12.5 mg
Trial: 6752873
Drug: Pirprofen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirprofen (1000 mg/day)
Trial: 6752873
Drug: Indomethacin (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (125 mg/day)
Trial: 27023596
Drug: Elderberry extract
RxNorm normalized name: elderberry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elderberry extract (Sambucus nigra L.)
Trial: 23521140
Drug: Chloroprocaine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroprocaine 40 mg (20 mg/ml)
Trial: 21039353
Drug: Articaine 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articaine 60 mg (40 mg/ml)
Trial: 17392739
Drug: 17.5 mg
RxNorm normalized name: acitretin 17.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17.5 mg hydrocortisone (cortisol)
Trial: 14760661
Drug: 800 ml
RxNorm normalized name: ALCOHOL 2660 mL in 3800 mL TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 ml of an iso-osmolar 12.5 percent carbohydrate-rich beverage (100 g carbohydrate) the evening before operation and another 400 ml (50 g carbohydrate) 2 hours before anaesthesia.
Trial: 11918251
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release metoprolol 95 mg
Trial: 9439530
Drug: Copper supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copper supplementation (2 mg/d for 4 weeks)
Trial: 7513853
Drug: Simple sequential
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple sequential method
Trial: 3428132
Drug: Ceftriaxone 100
RxNorm normalized name: ceftriaxone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 100 mg/kg (max 4 g) intravenously (i.v.) once daily
Trial: 3428132
Drug: Ampicillin i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin i.v. 160 mg/kg/day plus chloramphenicol i.v. 100 mg/kg/day every 6 h
Trial: 28157671
Drug: Wheat germ-enriched
RxNorm normalized name: WHEAT GERM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat germ-enriched bread (6 g of wheat germ)
Trial: 26024551
Drug: 6.4% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.4% carbohydrate solution (CHO)
Trial: 26024551
Drug: 6.4% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.4% carbohydrate and 4 mg/kg caffeine (C+C)
Trial: 23919853
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter and synchronous low dose intravaginal misoprostol
Trial: 23919853
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose intravaginal misoprostol alone
Trial: 21097434
Drug: Cerebral State
RxNorm normalized name: Sus scrofa cerebral cortex preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebral State Index (CSI) during target controlled infusion (TCI) of propofol
Trial: 10719590
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil (Zinnat, 2 x 250 mg/d)
Trial: 1313467
Drug: Oat bran
RxNorm normalized name: Oat bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oat bran diet (123 g oat bran for 4 weeks)
Trial: 1313467
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran diet (54 g wheat bran for 4 weeks)
Trial: 28877566
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no ginger capsules)
Trial: 25185858
Drug: Activated protein
RxNorm normalized name: Activated protein C
DrugBank: Drotrecogin alfa (DB00055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated protein C (APC) with Topical Negative Pressure (TNP)
Trial: 25185858
Drug: Topical Negative
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Negative Pressure (TNP) alone
Trial: 22209257
Drug: Rhinomanometry after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhinomanometry after nasal decongestant (ND) xylometazoline
Trial: 11249979
Drug: Azithromycin (31
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (31 patients) at a dose of 10 mg/kg once a week for 3 months
Trial: 11249979
Drug: Amoxicillin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (40 patients) at a dose of 20 mg/kg per day for 3 months
Trial: 7851352
Drug: naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen sodium 1100 mg 1 h prior to surgery
Trial: 7851352
Drug: naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen sodium 1100 mg immediately after surgery
Trial: 2755866
Drug: Topical 70%
RxNorm normalized name: ethanol topical 70% topical foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 70% dimethyl sulfoxide (DMSO)
Trial: 2755866
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% dimethyl sulfoxide (DMSO)
Trial: 341247
Drug: BCG immunotherapy
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG immunotherapy (75 mg of living BCG on a scratched area once a week)
Trial: 30665152
Drug: Relay model
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relay model (Danish screening brief intervention and referral to treatment)
Trial: 16176400
Drug: Active SLIT
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active SLIT for 1 year, followed by 2 years of active treatment
Trial: 30720541
Drug: Topical ripasudil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ripasudil 0.4% (Glanatec) 4 times a day for 2 months
Trial: 30720541
Drug: Topical ripasudil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ripasudil 0.4% (Glanatec)
Trial: 27528215
Drug: Education based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education based on phosphorus‐reducing techniques in food preparation and two hospital meals prepared using suggested cooking methods
Trial: 26442397
Drug: Neostigmine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine group (group N) received bupivacaine 20 mg combined with 25 µg neostigmine.
Trial: 26442397
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group C) received bupivacaine 20 mg combined with 0.5ml distilled water.
Trial: 14681344
Drug: YH1885 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 60 mg single dose
Trial: 14681344
Drug: YH1885 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 100 mg single dose
Trial: 14681344
Drug: YH1885 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 150 mg single dose
Trial: 14681344
Drug: YH1885 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 200 mg single dose
Trial: 14681344
Drug: YH1885 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 300 mg single dose
Trial: 14681344
Drug: YH1885 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 150 mg multiple doses (once-daily for 7 days)
Trial: 14681344
Drug: YH1885 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YH1885 300 mg multiple doses (once-daily for 7 days)
Trial: 30480487
Drug: Autologous Blood
RxNorm normalized name: Banked autologous blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous Blood Patch Injection (ABPI)
Trial: 23721033
Drug: Occlusal appliance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal appliance therapy
Trial: 19040623
Drug: Lodenafil carbonate
RxNorm normalized name: Lodenafil carbonate
DrugBank: Lodenafil carbonate (DB11927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodenafil carbonate 80 mg
Trial: 19040623
Drug: Lodenafil carbonate
RxNorm normalized name: Lodenafil carbonate
DrugBank: Lodenafil carbonate (DB11927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodenafil carbonate 40 mg
Trial: 19040623
Drug: Lodenafil carbonate
RxNorm normalized name: Lodenafil carbonate
DrugBank: Lodenafil carbonate (DB11927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodenafil carbonate 20 mg
Trial: 16546471
Drug: Isoflavone intake
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone intake (75 mg of isoflavones conjugates per day)
Trial: 31107300
Drug: Protease inhibitors
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitors
Trial: 9578788
Drug: DTPw-HB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw-HB vaccine
Trial: 29630706
Drug: Narrative emphasizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrative emphasizing systemic barriers to treatment
Trial: 29630706
Drug: Narrative emphasizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrative emphasizing successful treatment and recovery
Trial: 26823137
Drug: High volume
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High volume IV fluid (20 mL/kg bolus + 1.5 × maintenance rate)
Trial: 26823137
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume IV fluid (10 mL/kg bolus + 1.25 × maintenance rate)
Trial: 20106580
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg of tartrazine dye
Trial: 12600913
Drug: High-dose milrinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose milrinone (75-microg/kg bolus followed by a 0.75-microg/kg per min infusion for 35 hours)
Trial: 12600913
Drug: Low-dose milrinone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose milrinone (25-microg/kg bolus followed by a 0.25-microg/kg per min infusion for 35 hours)
Trial: 12600913
Drug: High-dose milrinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose milrinone
Trial: 11124928
Drug: 4% w/w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% w/w amethocaine gel
Trial: 3150950
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100 mg per day for 5 days (CC-5)
Trial: 3150950
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100 mg per day for 15 days (CC-15)
Trial: 15094260
Drug: Paroxetine combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine combined with cognitive group-therapy
Trial: 9547164
Drug: Cerebrospinal fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrospinal fluid (CSF) levels of soluble IL-6 receptor (sIL-6R) in AD patients
Trial: 8341439
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate cream 0.1% applied daily
Trial: 8341439
Drug: Betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone valerate cream 0.1% applied twice daily
Trial: 29141040
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (oral contraceptive pills Nordette® or Naproxen Naprosyn®)
Trial: 25377934
Drug: Control video
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control video (oral hygiene instruction)
Trial: 23937387
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER (25-200 mg bid)
Trial: 23937387
Drug: Oxycodone CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone CR (5-40 mg bid)
Trial: 18435378
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no intermediate agent applied)
Trial: 16598527
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation in high-risk patients with AF
Trial: 10837379
Drug: Dorzolamide 2%
RxNorm normalized name: Brimonidine Tartrate 0.1%, Dorzolamide 2% Ophthalmic drops, solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide 2% three times daily
Trial: 9397397
Drug: High-DHA diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-DHA diet (6 g/d of DHA in the form of a triglyceride containing 40% DHA)
Trial: 9397397
Drug: Low-DHA diet
RxNorm normalized name: Low-energy diets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-DHA diet (< 50 mg/d of DHA)
Trial: 29684832
Drug: Sucrose (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (0.2 ml/kg of 20%) plus non-nutritive sucking group
Trial: 29684832
Drug: Sucrose (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (0.2 ml/kg of 20%) group
Trial: 14730238
Drug: Fluconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (400 mg)
Trial: 17452906
Drug: Itraconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (400 mg)
Trial: 9308742
Drug: Short prophylaxis
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short prophylaxis with low molecular weight heparin (LMWH) during hospitalisation
Trial: 9308742
Drug: Prolonged prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged prophylaxis with low molecular weight heparin (LMWH) for three weeks after hospitalisation
Trial: 9308742
Drug: Short prophylaxis
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short prophylaxis with low molecular weight heparin (LMWH)
Trial: 7701033
Drug: Naltrexone, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone, 25 mg orally
Trial: 3661052
Drug: Aldosterone (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aldosterone (1.0 mg)
Trial: 3661052
Drug: Fluocortolone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocortolone (20 mg)
Trial: 3661052
Drug: Hydrocortisone (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (80 mg)
Trial: 26413749
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg daily oral spironolactone for 12 weeks
Trial: 23444322
Drug: Computer-based administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based administration of the STOFHLA
Trial: 23444322
Drug: Paper-based administration
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper-based administration of the STOFHLA
Trial: 22335183
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of naltrexone and brief counseling
Trial: 22335183
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard tuberculosis treatment without alcohol intervention)
Trial: 15911473
Drug: Saw palmetto
RxNorm normalized name: Saw palmetto
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saw palmetto (study medication)
Trial: 10814923
Drug: Heparin-coated circuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated circuits
Trial: 30178528
Drug: Experimental drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental drug
Trial: 7018165
Drug: Natural estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural estrogen (estradiol‐17 beta 4 mg + estriol 2 mg/norethisterone acetate 3 mg per tablet)
Trial: 7018165
Drug: Artificial estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial estrogen (ethinyl estradiol 50 micrograms/ norethisterone acetate 3 mg per tablet)
Trial: 31438790
Drug: Carpal Tunnel
RxNorm normalized name: Wristaleve Carpal Tunnel Brace
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carpal Tunnel Release surgery with Dexamethasone injection
Trial: 23652893
Drug: Nonsteroidal cream
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal cream (Promiseb® Topical Cream); applied topically twice daily for up to 14 days
Trial: 23652893
Drug: Placebo cream;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream; applied topically twice daily for up to 14 days
Trial: 23652893
Drug: Nonsteroidal cream
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal cream
Trial: 21856230
Drug: Corifollitropin alfa
RxNorm normalized name: corifollitropin alfa
DrugBank: Corifollitropin alfa (DB09066)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Corifollitropin alfa (150 μg)
Trial: 21856230
Drug: Daily recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily recombinant FSH (rFSH) (200 IU)
Trial: 19565745
Drug: Bee-needle therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bee-needle therapy
Trial: 17448376
Drug: BNP-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNP-guided therapy (goal of decreasing BNP plasma levels <100 pg/ml)
Trial: 17448376
Drug: Clinical group
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical group (medical treatment according to current guidelines)
Trial: 15334509
Drug: Tobramycin solution
RxNorm normalized name: Tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin solution for inhalation (TSI); 28 days of twice-daily inhalation followed by 28 days off for 56 weeks
Trial: 11568032
Drug: Chronic calcium
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic calcium channel blocker therapy (CCCBT) continued with diltiazem (120 mg/d) for 5 years
Trial: 11568032
Drug: Suspension of
RxNorm normalized name: Suspension of heat killed (autoclaved) Mycobacterium w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension of chronic calcium channel blocker therapy (CCCBT)
Trial: 2199619
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (60 weeks)
Trial: 686545
Drug: Reinforced disulfiram
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reinforced disulfiram treatment (methadone contingent upon disulfiram ingestion)
Trial: 21197512
Drug: HS +
RxNorm normalized name: HS-CoM
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HS + LA (2% lidocaine in 0.2 ml)
Trial: 21197512
Drug: HS +
RxNorm normalized name: HS-CoM
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HS + ketorolac (3 mg in 0.2 mL)
Trial: 18295556
Drug: Clopidogrel preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel preparation 1
Trial: 18295556
Drug: Clopidogrel preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel preparation 2
Trial: 8778554
Drug: Eleutherococcus senticosus
RxNorm normalized name: Eleutherococcus Senticosus Root
DrugBank: Eleuthero (DB14303)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eleutherococcus senticosus Maxim L (ESML)
Trial: 1667345
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated varicella vaccine (LAVV)
Trial: 6360936
Drug: Pirenzepine 50
RxNorm normalized name: pirenzepine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 50 mg daily (group A)
Trial: 6360936
Drug: Pirenzepine 100
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 100 mg daily (group B)
Trial: 31813866
Drug: 1% aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% aspirin gel
Trial: 31813866
Drug: 1% aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% aspirin mouthwash
Trial: 24163120
Drug: Rosuvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (20 mg once daily for 6 weeks)
Trial: 24163120
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg once daily for 6 weeks)
Trial: 20606658
Drug: venlafaxine 75
RxNorm normalized name: venlafaxine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venlafaxine 75 mg q.h.s. for 4 weeks